---
title: "Haiqing Zhiyuan falls over 10% to new low of HKD 14.56"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292453196.md"
description: "HAIQING ZHIYUAN (1392.HK) plunged over 10% in Hong Kong trading to a record low of HKD 14.56, closing at HKD 15.10 amid volatile session."
datetime: "2026-07-13T07:50:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292453196.md)
  - [en](https://longbridge.com/en/news/292453196.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292453196.md)
---

# Haiqing Zhiyuan falls over 10% to new low of HKD 14.56

Haiqing Zhiyuan (1392.HK) **tumbled** over 10% during regular trading to **HKD 15.10**.

The stock hit a historic low of **HKD 14.56** intraday. Although it spiked more than 3% within five minutes, the overall trend remained weak, ending with a sharp decline.

### Related Stocks

- [01392.HK](https://longbridge.com/en/quote/01392.HK.md)

## Related News & Research

- [US and Iran are 'competing' over who exacts how much toll at Hormuz: Expert](https://longbridge.com/en/news/292577508.md)
- [CGN New Energy Holdings (SEHK:1811) After Mixed Output Data Is The Stock A Bargain](https://longbridge.com/en/news/292462110.md)
- [CNGR Forecasts Strong Interim Profit Surge on Robust Battery Materials Demand](https://longbridge.com/en/news/292492787.md)
- [Does New Offshore Wind and Hydropower Contract Surge Change The Bull Case For Aker Solutions (OB:AKSO)?](https://longbridge.com/en/news/292407567.md)
- [Fujian Haixi Pharma says China NMPA clears HXP089 IND for glioblastoma trial](https://longbridge.com/en/news/292595883.md)